Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Oncology|October 20, 2004
Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-alpha combination chemotherapyMasaru Moriyama, Yujin Hoshida, Naoya Kato, et al.
Hepatology International|August 12, 2009
Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5AMasaru Moriyama, Naoya Kato, Motoyuki Otsuka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis CNarayan Dharel, Naoya Kato, Ryosuke Muroyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 14, 2004
A simple combination of serum type IV collagen and prothrombin time to diagnose cirrhosis in patients with chronic active hepatitis CYi Qiu, Yujin Hoshida, Naoya Kato, et al.
Hepatology (Baltimore, Md.)|April 21, 2005
Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responsesMotoyuki Otsuka, Naoya Kato, Masaru Moriyama, et al.
Hepato-Gastroenterology|May 26, 2007
Gene expressions associated with chemosensitivity in human hepatoma cellsYujin Hoshida, Masaru Moriyama, Motoyuki Otsuka, et al.
Gastroenterology|January 6, 2005
Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathwaysRun-Xuan Shao, Motoyuki Otsuka, Naoya Kato, et al.
The Journal of Infectious Diseases|February 25, 2003
Synergistic activation of the serum response element-dependent pathway by hepatitis B virus x protein and large-isoform hepatitis delta antigenTadashi Goto, Naoya Kato, Hideo Yoshida, et al.
Pageof 3